Lorenzo Piemonti
@piemontil.bsky.social
Director Diabetes Research Institute and Clinic Unit of Regenerative Medicine and Organ Transplants, Professor of endocrinology Universita Vita-Salute San Raffaele, Milan, Italy
Un grazie a Radio 24 per l’invito a Il Cowboy e lo Stivale. Stimolante il confronto con Giuseppe Remuzzi e Andrew Spannaus su sanità, obesità e diabete: come abitudini, ambiente e politiche sanitarie plasmano la nostra salute.
www.radio24.ilsole24ore.com/programmi/Il...
#Diabete #Obesità #Radio24
www.radio24.ilsole24ore.com/programmi/Il...
#Diabete #Obesità #Radio24
Radio24 | Il Sole 24 ORE
Ascolta Radio 24, la radio de Il Sole 24 ORE: news, notiziari, borsa e guide in tempo reale. La radio online in formato mp3 e podcast scaricabili.
www.radio24.ilsole24ore.com
September 5, 2025 at 6:41 AM
Un grazie a Radio 24 per l’invito a Il Cowboy e lo Stivale. Stimolante il confronto con Giuseppe Remuzzi e Andrew Spannaus su sanità, obesità e diabete: come abitudini, ambiente e politiche sanitarie plasmano la nostra salute.
www.radio24.ilsole24ore.com/programmi/Il...
#Diabete #Obesità #Radio24
www.radio24.ilsole24ore.com/programmi/Il...
#Diabete #Obesità #Radio24
🧬 New case report in Acta Diabetologica: 10-year follow-up of islet transplantation in a patient with Wolfram syndrome.
Non-autoimmune, insulinopenic diabetes — still responsive to beta-cell replacement.
Rethinking eligibility.
🔗 doi.org/10.1007/s005...
#Diabetes #IsletTx
Non-autoimmune, insulinopenic diabetes — still responsive to beta-cell replacement.
Rethinking eligibility.
🔗 doi.org/10.1007/s005...
#Diabetes #IsletTx
Long-term follow-up of pancreatic islet transplantation in a patient with Wolfram syndrome: a case report - Acta Diabetologica
Acta Diabetologica -
doi.org
July 30, 2025 at 9:33 AM
🧬 New case report in Acta Diabetologica: 10-year follow-up of islet transplantation in a patient with Wolfram syndrome.
Non-autoimmune, insulinopenic diabetes — still responsive to beta-cell replacement.
Rethinking eligibility.
🔗 doi.org/10.1007/s005...
#Diabetes #IsletTx
Non-autoimmune, insulinopenic diabetes — still responsive to beta-cell replacement.
Rethinking eligibility.
🔗 doi.org/10.1007/s005...
#Diabetes #IsletTx
“Pole pole” — I learned it climbing Kilimanjaro: slow, steady, with respect.
Now it’s the spirit of our new @AmJTransplant commentary on cautiously exploring IAT in IPMN patients.
Science moves best when it listens.
👉 doi.org/10.1016/j.aj...
#IAT #IPMN #PolePole
Now it’s the spirit of our new @AmJTransplant commentary on cautiously exploring IAT in IPMN patients.
Science moves best when it listens.
👉 doi.org/10.1016/j.aj...
#IAT #IPMN #PolePole
Redirecting
doi.org
July 25, 2025 at 6:17 PM
“Pole pole” — I learned it climbing Kilimanjaro: slow, steady, with respect.
Now it’s the spirit of our new @AmJTransplant commentary on cautiously exploring IAT in IPMN patients.
Science moves best when it listens.
👉 doi.org/10.1016/j.aj...
#IAT #IPMN #PolePole
Now it’s the spirit of our new @AmJTransplant commentary on cautiously exploring IAT in IPMN patients.
Science moves best when it listens.
👉 doi.org/10.1016/j.aj...
#IAT #IPMN #PolePole
How should we assess graft function after islet autotransplantation?
A study from @SanRaffaeleMI compares 6 outcome classification systems—including a data-driven model that better captures intermediate outcomes.
www.frontierspartnerships.org/journals/tra...
A study from @SanRaffaeleMI compares 6 outcome classification systems—including a data-driven model that better captures intermediate outcomes.
www.frontierspartnerships.org/journals/tra...
Frontiers Publishing Partnerships | Comparative Analysis of Islet Auto-Transplantation Outcome Classification Systems: Evaluating Concordance, Feasibility, and a Data-Driven Approach
A standardized approach to assessing islet autotransplantation outcomes is crucial for evaluating graft function and guiding clinical decisions. This study c...
www.frontierspartnerships.org
July 25, 2025 at 6:03 PM
How should we assess graft function after islet autotransplantation?
A study from @SanRaffaeleMI compares 6 outcome classification systems—including a data-driven model that better captures intermediate outcomes.
www.frontierspartnerships.org/journals/tra...
A study from @SanRaffaeleMI compares 6 outcome classification systems—including a data-driven model that better captures intermediate outcomes.
www.frontierspartnerships.org/journals/tra...
Can β-cell replacement therapies for type 1 diabetes move beyond being a last resort?
In this new Diabetes article, we explore what’s possible, what’s needed, and what questions remain.
📄 doi.org/10.2337/dbi2...
#T1D #BetaCell #DiabetesResearch
In this new Diabetes article, we explore what’s possible, what’s needed, and what questions remain.
📄 doi.org/10.2337/dbi2...
#T1D #BetaCell #DiabetesResearch
Future Directions and Clinical Trial Considerations for Novel Islet β-Cell Replacement Therapies for Type 1 Diabetes
Type 1 diabetes results from the immune-mediated loss of insulin-producing pancreatic islet β-cells, rendering those affected dependent on exogenous insuli
doi.org
July 15, 2025 at 10:01 PM
Can β-cell replacement therapies for type 1 diabetes move beyond being a last resort?
In this new Diabetes article, we explore what’s possible, what’s needed, and what questions remain.
📄 doi.org/10.2337/dbi2...
#T1D #BetaCell #DiabetesResearch
In this new Diabetes article, we explore what’s possible, what’s needed, and what questions remain.
📄 doi.org/10.2337/dbi2...
#T1D #BetaCell #DiabetesResearch
#ESPEESE2025 has just wrapped up in Copenhagen!
We joined the Meet the Expert session on #Type1Diabetes therapies as guests from the DRI @SanRaffaeleMI.
The real challenge? Endocrine care that follows the patient across their whole life.
Easy to say… hard to do… but not impossible.
#SanRaffaeleMI
We joined the Meet the Expert session on #Type1Diabetes therapies as guests from the DRI @SanRaffaeleMI.
The real challenge? Endocrine care that follows the patient across their whole life.
Easy to say… hard to do… but not impossible.
#SanRaffaeleMI
May 13, 2025 at 2:06 PM
#ESPEESE2025 has just wrapped up in Copenhagen!
We joined the Meet the Expert session on #Type1Diabetes therapies as guests from the DRI @SanRaffaeleMI.
The real challenge? Endocrine care that follows the patient across their whole life.
Easy to say… hard to do… but not impossible.
#SanRaffaeleMI
We joined the Meet the Expert session on #Type1Diabetes therapies as guests from the DRI @SanRaffaeleMI.
The real challenge? Endocrine care that follows the patient across their whole life.
Easy to say… hard to do… but not impossible.
#SanRaffaeleMI
We’re excited to share our latest work published in the American Journal of Transplantation: Islet Autotransplantation in Focal Intraductal Papillary Mucinous Neoplasms: Evaluating Feasibility, Safety, and Metabolic Outcomes in Pancreatic Resection kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
kwnsfk27.r.eu-west-1.awstrack.me
April 23, 2025 at 7:26 PM
We’re excited to share our latest work published in the American Journal of Transplantation: Islet Autotransplantation in Focal Intraductal Papillary Mucinous Neoplasms: Evaluating Feasibility, Safety, and Metabolic Outcomes in Pancreatic Resection kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
April 11, 2025 – National Day for Organ Donation and Transplantation.
The breath becomes silence, but it doesn’t end.
Time just changes its body.
#OrganDonation #DonateLife #April11
www.facebook.com/share/v/1HSJ...
The breath becomes silence, but it doesn’t end.
Time just changes its body.
#OrganDonation #DonateLife #April11
www.facebook.com/share/v/1HSJ...
Redirecting...
www.facebook.com
April 13, 2025 at 5:37 PM
April 11, 2025 – National Day for Organ Donation and Transplantation.
The breath becomes silence, but it doesn’t end.
Time just changes its body.
#OrganDonation #DonateLife #April11
www.facebook.com/share/v/1HSJ...
The breath becomes silence, but it doesn’t end.
Time just changes its body.
#OrganDonation #DonateLife #April11
www.facebook.com/share/v/1HSJ...
We’ve been exploring the potential of GLP-1 receptor agonists for treating Wolfram Syndrome, a rare form of diabetes.
#WolframSyndrome #GLP1 diabetesjournals.org/diabetes/art...
#WolframSyndrome #GLP1 diabetesjournals.org/diabetes/art...
Liraglutide treatment reverses unconventional cellular defects in induced pluripotent stem cell-derived β cells harboring a partially functional WFS1 variant
Wolfram Syndrome 1 (WS1) is a rare genetic disorder caused by WFS1 variants that disrupt Wolframin, an endoplasmic reticulum-associated protein essential f
diabetesjournals.org
April 9, 2025 at 8:00 PM
We’ve been exploring the potential of GLP-1 receptor agonists for treating Wolfram Syndrome, a rare form of diabetes.
#WolframSyndrome #GLP1 diabetesjournals.org/diabetes/art...
#WolframSyndrome #GLP1 diabetesjournals.org/diabetes/art...
Just published www.frontierspartnerships.org/journals/tra...
Frontiers Publishing Partnerships | The Last Mile in Beta-Cell Replacement Therapy for Type 1 Diabetes: Time to Grow Up
Beta cell replacement therapy for type 1 diabetes (T1D) is undergoing a transformative shift, driven by advances in stem cell biology, gene editing, and tiss...
www.frontierspartnerships.org
April 1, 2025 at 5:23 PM
Just published www.frontierspartnerships.org/journals/tra...
Bringing new therapy to patients needs strong clinical trials and regulatory alignment. Europe is updating GCP guidelines (ICH E6(R3)) to boost efficiency while ensuring safety and transparency
💡 Why does it matter?
To deliver innovative therapies faster.
#CellTherapies #Diabetes #GCP #ACTEUworkshop
💡 Why does it matter?
To deliver innovative therapies faster.
#CellTherapies #Diabetes #GCP #ACTEUworkshop
February 20, 2025 at 11:24 AM
Bringing new therapy to patients needs strong clinical trials and regulatory alignment. Europe is updating GCP guidelines (ICH E6(R3)) to boost efficiency while ensuring safety and transparency
💡 Why does it matter?
To deliver innovative therapies faster.
#CellTherapies #Diabetes #GCP #ACTEUworkshop
💡 Why does it matter?
To deliver innovative therapies faster.
#CellTherapies #Diabetes #GCP #ACTEUworkshop
A long story about our activity just published
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy - The Lancet Diabetes & Endocrinology www.thelancet.com/journals/lan...
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy - The Lancet Diabetes & Endocrinology www.thelancet.com/journals/lan...
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy
This analysis of a large islet transplantation alone cohort provides valuable insights
into factors influencing outcomes and highlights potential risks, supporting informed
clinical decision making an...
www.thelancet.com
February 19, 2025 at 3:28 PM
A long story about our activity just published
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy - The Lancet Diabetes & Endocrinology www.thelancet.com/journals/lan...
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy - The Lancet Diabetes & Endocrinology www.thelancet.com/journals/lan...